ArticleViruses2024

Enhanced Anti-Tumor Response Elicited by a Novel Oncolytic Pseudorabies Virus Engineered with a PD-L1 Inhibitor.

Guangtao Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.